Eir Partners recaps healthcare software and tech firm ClaimLogiq

The investment will be used for new product development and automation.

  • ClaimLogiq was founded in 2013
  • Eir Partners invests in health tech and tech enabled companies
  • Eir has completed or partnered on over $4.2 billion in healthcare technology transactions since inception in 2015

Eir Partners has closed the growth recapitalization of Charleston, South Carolina-based ClaimLogiq, a healthcare software and tech firm. No financial terms were disclosed.

Eir Partners’ strategy is to leverage ClaimLogiq as a platform investment and continue to aggressively invest in new product development and automation to broaden its portfolio of adjacent solutions. Additionally, the company plans to complement organic growth through synergistic acquisitions that deliver actionable data analytics, scalable partnerships, and content rich results to increase savings and work in collaboration with health plan partners. Since the Eir Partners investment, ClaimLogiq has completed the acquisitions of itemized bill review company, Medliminal, and SyTrue, a health care focused natural language processing technology company.

ClaimLogiq was founded in 2013.

Brett Carlson, a managing partner at Eir Partners, said in a statement, “We have over 15 years of experience in the healthcare payment accuracy space having been on the board of Equian and the founding investors of CloudMed. With our investment in ClaimLogiq, we want to build on all the learnings and experiences we have had to be a market disruptor to the old way of conducting payment integrity reviews. We are confident this will be the next generation solution for U.S. health plans to better manage payment accuracy.”

Eir Partners invests in health tech and tech enabled companies. Eir’s investment platform includes direct platform investments as the sole investor or alongside strategic or other private equity firms. Eir has completed or partnered on over $4.2 billion in healthcare technology transactions since inception in 2015 and has been involved in several large scale health tech companies including CloudMed, Equian, Millennia, Convey and others. Targeted stages of investment include growth equity through control buyouts.